MEASURING THE FUNCTIONAL IMPACT OF FATIGUE - INITIAL VALIDATION OF THE FATIGUE IMPACT SCALE

被引:1072
作者
FISK, JD
RITVO, PG
ROSS, L
HAASE, DA
MARRIE, TJ
SCHLECH, WF
机构
[1] VICTORIA GEN HOSP,DEPT MED,HALIFAX,NS,CANADA
[2] VICTORIA GEN HOSP,DEPT PSYCHOL,HALIFAX,NS,CANADA
[3] DALHOUSIE UNIV,DEPT PSYCHIAT,HALIFAX,NS,CANADA
[4] DALHOUSIE UNIV,DEPT PSYCHOL,HALIFAX,NS,CANADA
[5] DALHOUSIE UNIV,DEPT MED,HALIFAX,NS,CANADA
关键词
D O I
10.1093/clinids/18.Supplement_1.S79
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was > .87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patients' attribution of functional limitations to symptoms of fatigue.
引用
收藏
页码:S79 / S83
页数:5
相关论文
共 14 条
[1]  
[Anonymous], 1971, EITS MANUAL PROFILE
[2]  
BERGNER M, 1976, MED CARE, V14, P146
[3]  
FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135
[4]  
GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441
[5]   CHRONIC FATIGUE SYNDROME [J].
KLONOFF, DC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (05) :812-823
[6]   CHRONIC FATIGUE IN PRIMARY CARE - PREVALENCE, PATIENT CHARACTERISTICS, AND OUTCOME [J].
KROENKE, K ;
WOOD, DR ;
MANGELSDORFF, AD ;
MEIER, NJ ;
POWELL, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (07) :929-934
[7]   THE FATIGUE SEVERITY SCALE - APPLICATION TO PATIENTS WITH MULTIPLE-SCLEROSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
KRUPP, LB ;
LAROCCA, NG ;
MUIRNASH, J ;
STEINBERG, AD .
ARCHIVES OF NEUROLOGY, 1989, 46 (10) :1121-1123
[8]  
Monks J, 1989, Int Disabil Stud, V11, P78
[9]   AMANTADINE THERAPY FOR FATIGUE IN MULTIPLE-SCLEROSIS [J].
MURRAY, TJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (03) :251-254
[10]   DEVELOPMENT OF A MEASURE OF SYMPTOMS IN CHRONIC FATIGUE SYNDROME - THE PROFILE OF FATIGUE-RELATED SYMPTOMS (PFRS) [J].
RAY, C ;
WEIR, WRC ;
PHILLIPS, S ;
CULLEN, S .
PSYCHOLOGY & HEALTH, 1992, 7 (01) :27-43